carotid stent News
-
InspireMD Receives Reimbursement Approval for CGuard™ Embolic Prevention System from the French National Authority for Health
InspireMD, Inc. (Nasdaq: NSPR), a global developer of the CGuard™ Embolic Prevention Stent System (EPS) device for the treatment of Carotid Artery Disease (CAD) and stroke prevention, today announced that its CGuard EPS stent system has received a positive opinion from the National Commission for the Evaluation of Medical Devices and Health Technologies (CNEDIMTS) of the French National ...
-
InspireMD Announces Publication of 12-Month Results of CGuard™ EPS SIBERIA Trial in Journals of the American College of Cardiology: Cardiovascular Interventions
InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard™ Embolic Prevention System (EPS) for the prevention of stroke caused by the treatment of Carotid Artery Disease (CAD), today announced that results from the investigator-initiated SIBERIA randomized clinical trial of CGuard EPS, that evaluated the peri-procedural and 30-day silent brain infarcts associated with the use of its ...
-
Robocath successfully performs first carotid stenting in France with R-One robot at Rennes University Hospital
Robocath, a company that designs, develops and commercializes innovative robotic platforms for the treatment of vascular diseases, announces today its successful first robotic carotid stenting at Rennes University Hospital. This breakthrough in the neurovascular field was performed on November 16, using Robocath’s R-One robot, operated by Dr. François Eugène and his team. The ...
By Robocath
-
Galway’s Shortcut to Global Success with its Med-Tech Startups
The city’s med tech cluster has been the springboard for a start-up which, armed with almost €30m in funding, is on the cusp of a global breakthrough. ARTICLE FROM IRISH INDEPENDENT printed 16.04.16 Pictured in the Veryan Medical R&D Centre, Galway were (from left) Chas Taylor (Chief Executive Officer) and Paul Gilson (Chief Scientific Officer). Photo: Yann Studios. ...
-
InspireMD Enrolls and Treats First Patients at Ballad Health System in U.S. Registration C-Guardian Clinical Trial of CGuard EPS
InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard™ Embolic Prevention Stent System (EPS) device for the treatment of Carotid Artery Disease (CAD) and stroke prevention, today announces the initiation of enrollment and successful completion of the first cases of the Company’s U.S. registration C-Guardian trial of CGuard EPS. The first patients, who were under the care of ...
-
First Ever Standard Surgical Risk Patient TCAR Data to be Presented at the Society for Vascular Surgery 2021 Vascular Annual Meeting
Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced that key data regarding standard risk patients undergoing treatment for atherosclerotic carotid disease, including patients undergoing carotid endarterectomy (CEA) and transcarotid artery revascularization (TCAR), will be presented at the upcoming Society for ...
-
News Find here our latest news and events to come Search an article Robocath successfully performs first carotid stenting in France with R-One robot at Rennes University Hospital 24 November 2021 Rouen, France, November 24, 2021 - Robocath, a company
Robocath, a company that designs, develops and commercializes robotic solutions to treat cardiovascular diseases, and Rennes University Hospital, today announce the launch of a co-development research program using robotics to improve treatment for stroke victims. With the support of Philips France, this unique program will be implemented over the next four years. It will focus on the use of ...
By Robocath
-
InspireMD Announces Strong Second Quarter 2021 Financial Results
InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard™ Embolic Prevention System (EPS) for the prevention of stroke caused by the treatment of Carotid Artery Disease (CAD), today announced financial and operating results as of and for the second quarter ended June 30, 2021. Second Quarter 2021 and recent highlights Revenue of $1,038,000 an increase of 231.6% compared to the same ...
-
Oncomfort and Vygon sign international partnership for commercialization of Sedakit™, the Digital Sedation™ Virtual Reality solution
Oncomfort, the Belgian inventor of Digital SedationTM - a new method for relieving patients’ pain and anxiety without medication –, and Vygon, global group specializing in single-use medical devices, today announce their commercial partnership in six European countries. The strong synergy between Vygon's specialization and Oncomfort's fields of application will enable greater ...
By Oncomfort
-
Silk Road Medical Announces FDA Approval of Expanded Indications for the ENROUTE Transcarotid Stent System
Silk Road Medical, Inc.?(Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced that that the U.S. Food and Drug Administration (FDA) approved expanded indications for the ENROUTE stent to include patients at standard risk for adverse events from carotid endarterectomy (CEA). Previously, the stent was approved for use only in patients with ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you